Certara (NASDAQ:CERT) Shares Gap Up to $14.02

Certara, Inc. (NASDAQ:CERT) gapped up prior to trading on Wednesday . The stock had previously closed at $14.02, but opened at $14.41. Certara shares last traded at $14.05, with a volume of 18,961 shares trading hands.

Wall Street Analyst Weigh In

Several analysts have recently commented on the company. Barclays lowered their price objective on Certara from $18.00 to $16.00 and set an “equal weight” rating for the company in a research note on Friday, June 28th. JMP Securities reissued a “market perform” rating on shares of Certara in a research report on Wednesday. Finally, KeyCorp upgraded Certara from a “sector weight” rating to an “overweight” rating and set a $23.00 price objective on the stock in a research note on Wednesday, April 10th. Seven analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to data from MarketBeat, Certara currently has an average rating of “Hold” and an average price target of $19.81.

Certara Trading Down 0.9 %

The firm has a fifty day moving average of $15.65 and a two-hundred day moving average of $16.72. The company has a market cap of $2.24 billion, a PE ratio of -35.64, a price-to-earnings-growth ratio of 4.93 and a beta of 1.52. The company has a current ratio of 3.26, a quick ratio of 3.26 and a debt-to-equity ratio of 0.27.

Certara (NASDAQ:CERT) last released its quarterly earnings data on Tuesday, May 7th. The company reported $0.06 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.07 by ($0.01). Certara had a negative net margin of 17.02% and a positive return on equity of 4.08%. The company had revenue of $96.65 million for the quarter, compared to the consensus estimate of $94.48 million. As a group, sell-side analysts predict that Certara, Inc. will post 0.28 EPS for the current year.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the company. Mubadala Investment Co PJSC purchased a new stake in shares of Certara in the fourth quarter worth $169,135,000. Franklin Resources Inc. raised its holdings in shares of Certara by 8.2% in the 4th quarter. Franklin Resources Inc. now owns 1,820,864 shares of the company’s stock valued at $32,029,000 after acquiring an additional 138,682 shares in the last quarter. Edmond DE Rothschild Holding S.A. boosted its position in shares of Certara by 93.1% during the 4th quarter. Edmond DE Rothschild Holding S.A. now owns 769,300 shares of the company’s stock valued at $13,532,000 after acquiring an additional 370,820 shares during the last quarter. Norges Bank purchased a new position in shares of Certara during the fourth quarter worth about $14,262,000. Finally, Wasatch Advisors LP grew its holdings in shares of Certara by 23.4% during the first quarter. Wasatch Advisors LP now owns 4,924,845 shares of the company’s stock worth $88,056,000 after purchasing an additional 932,598 shares in the last quarter. 73.96% of the stock is currently owned by hedge funds and other institutional investors.

About Certara

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.